Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2012; 18(37): 5188-5196
Published online Oct 7, 2012. doi: 10.3748/wjg.v18.i37.5188
Table 1 Clinical characteristics of participants in validation
GroupCHBNASHCtrl
Individuals (n)242024
Gender (n)
Male211719
Female335
Age (yr)37.6 ± 9.039.4 ± 9.635.6 ± 10.2
ALT (IU/L)82.6 (14-412)51.7 (18-203)21.5 (14-43)
AST (IU/L)62.6 (9-206)31.55 (17-62)21.4 (16-49)
GGT (IU/L)69.4 (10-580)45.8 (13-124)20.8 (12-33)
ALP (IU/L)95.8 (51-211)66.0 (41-90)62.3 (42-96)
TBIL (μmol/L)19.2 (10.2-50.7)19.5 (13.1-31.7)15.9 (6.9-27.1)
HBV DNA7 377 395 (0-94 800 000)00
Bile acid (μmol/L)6.9 (1.4-13)17.9 (3-118.7)8.4 (4.1-12)
HBV status (n)
HBsAg+2400
HBsAg-02024